XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating expenses:    
Research and development $ 8,033 $ 10,358
General and administrative 5,460 5,020
Total operating expenses 13,493 15,378
Loss from operations (13,493) (15,378)
Other income (expense):    
Interest and investment income 2,321 56
Other expense, net (16) (1)
Total other income, net 2,305 55
Net loss $ (11,188) $ (15,323)
Net loss per share attributable to common shareholders - basic $ (0.40) $ (1.18)
Net loss per share attributable to common shareholders - diluted $ (0.40) $ (1.18)
Weighted-average common shares outstanding used in net loss per share - basic 27,944,458 13,016,955
Weighted-average common shares outstanding used in net loss per share - diluted 27,944,458 13,016,955